Evaluation of the usefulness of a new protocol (Shizuoka protocol 2011) for the treatment of Kawasaki disease

Evaluation of the usefulness of a new protocol (Shizuoka protocol 2011) for the treatment of Kawasaki disease - Treatment of Kawasaki disease by a Shizuoka protocol 2011

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012741

Enrollment

500

Registered

2014-01-01

Start date

2011-08-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

An intensified second line therapy group: patients who did not respond to a standard first line therapy with IVIG (2g/kg) and showed post-IVIG CRP levels higher than 10mg/dl are treated with the seco

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Kawasaki disease diagnostic criteria 4/6 or more

Exclusion criteria

Exclusion criteria: Kawasaki disease diagnostic criteria less than 4/6

Design outcomes

Primary

Measure	Time frame
Quick subsidence of inflammation	—

Secondary

Measure	Time frame
Decrease in the incidenece of chronic CALs	—

Countries

Japan

Contacts

Public ContactMitsuaki Kimura

Shizuoka Children's Hospital Department of Allergy and Clinical Immunology

kimurami@sch.pref.shizuoka.jp054-247-6251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026